Consumer advertising of S3 draws strong opposition
In their pre-budget submission, the Australian Self-Medication Industry (ASMI) said there was an opportunity for community pharmacists to have a bigger role as a first port of call for a range of common conditions.
“Current arrangements whereby consumers are not allowed to know about medicines that are available without prescription mean that they continue to consult GPs for conditions which could be appropriately managed by a pharmacist,” ASMI executive director Deon Schoombie said.
But AMA president Dr Steve Hambleton said there were very good reasons for restrictions on advertising of Schedule 3 medicines.
“Not knowing what you don’t know is part of the problem,” he said.
“If you have a cold and buy Lemsip and then have a headache and take Panadeine you can have an overdose situation because people don’t realise that paracetamol is in both products.
“We don’t want to